Medicine. Transatlantic lessons in regulation of mitochondrial replacement therapy

Science. 2015 Apr 10;348(6231):178-80. doi: 10.1126/science.aaa8153. Epub 2015 Apr 9.

Authors

I Glenn Cohen¹, Julian Savulescu², Eli Y Adashi³

Affiliations

¹ Harvard Law School, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard University, Cambridge, MA, USA. igcohen@law.harvard.edu.
² Oxford Uehiro Centre for Practical Ethics, University of Oxford, Oxford, UK.
³ Warren Alpert Medical School, Brown University, Providence, RI, USA.

PMID: 25859028
DOI: 10.1126/science.aaa8153

No abstract available

Publication types

Comparative Study

MeSH terms

Clinical Trials as Topic
DNA, Mitochondrial / genetics*
Genetic Therapy / ethics
Genetic Therapy / legislation & jurisprudence*
Government Regulation*
Humans
Mitochondrial Diseases / genetics*
Mitochondrial Diseases / prevention & control*
Mitochondrial Diseases / therapy
Public Policy
United Kingdom
United States
United States Food and Drug Administration / legislation & jurisprudence

Substances

DNA, Mitochondrial